Ambroxol in Parkinson’s: Results of Phase ll Trial Published

Ambroxol in Parkinson’s: Results of Phase ll Trial Published
PLEASE DONATE TO HELP CPT FUND FURTHER RESEARCH Today The Cure Parkinson's Trust, in partnership with the Van Andel Institute and the John Black Charitable Foundation, is proud to announce the publication of the results of a Phase II clinical trial that evaluated the safety and tolerability of a drug called ambroxol to treat Parkinson's. In late 2014, the Linked ... read more
Source: The Cure Parkinson’s TrustPublished on 2020-01-13